To navigate shifting US tariff policies and the demand for localized supply chains, TCI Co. (大江生醫) has finalized the purchase of its Utah manufacturing plant for US$26.2 million, transitioning from a lease to full ownership.

• City Factory Strategy: Chairman Vincent Lin emphasized the "City Factory" model—highly automated, small-scale lines located near major market hubs to reduce lead times and logistics costs.
• Technical Innovation: The new DNZ (Double Nutri Zero) line, a global-first anaerobic liquid sachet technology, is set for US production in May. It solves the oxidation instability of high-activity ingredients, creating a high technical barrier.
• Financial Outlook: With high visibility on North American orders, TCI expects the new production line to break even within a year, with revenue anticipated to jump significantly in Q2 and Q3 2026.

Resource: 大江攻美 全面啟動在地製造